Although improvements in VA were numerically superior in treatment-naïve individuals, this did not reach statistical significance – possibly owing to the modest number of patients who had received prior anti-VEGF therapy.
← all excerpts
Treatment of Diabetic Macular Edema or Macular Edema Following Retinal Vein Occlusion Based on Repeated Injection of the Dexamethasone Intravitreal Implant: A Retrospective Real-World Analysis.
2
—
—
The sentences
There was a borderline significant association between baseline CMT and subsequent changes in VA following initial DEX treatment; patients with baseline CMT < 400 μm maintained improvements in VA beyond 3 months whereas those with baseline CMT ≥ 400 μm did not ( P =0.06) ( Figure 2B ).